FIELD: medicine, pharmaceutics.
SUBSTANCE: present invention refers to methods for preparing macrolides, e.g. compounds of formula (IV) and intermediate compounds of formula (V):
and 
, wherein R1-R12 have the values specified in the description.
EFFECT: compounds of formula V are valuable for treating inflammatory or immune disorders, and treating cancer.
12 cl, 12 dwg, 18 ex
| Title | Year | Author | Number |
|---|---|---|---|
| INTERMEDIATE PRODUCTS IN SYNTHESIS OF ANALOGUES OF ZEARALENONE MACROLIDES | 2008 |
|
RU2497803C2 |
| NEUROACTIVE COMPOUNDS AND THEIR APPLICATION METHODS | 2015 |
|
RU2764702C2 |
| 19-NOR C3, 3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF USE THEREOF | 2014 |
|
RU2675855C2 |
| JAK KINASE-MODULATING QUINAZOLINE DERIVATIVES AND METHODS OF APPLYING THEREOF | 2010 |
|
RU2529019C2 |
| 19-NOR C3,3-DISUBSTITUTED C21-N-PYRAZOLYL STEROIDS AND METHODS OF THEIR USE | 2014 |
|
RU2812930C2 |
| REDUCTION OF TUMOR MASS BY INJECTING CCR1 ANTAGONISTS IN COMBINATION WITH PD-1 INHIBITORS OR PD-L1 INHIBITORS | 2017 |
|
RU2745195C2 |
| ISOXAZOLINE AS FATTY ACID AMIDE HYDROLASE INHIBITORS | 2010 |
|
RU2539595C2 |
| NEUROACTIVE STEROIDS SUBSTITUTED AT POSITION 10 WITH A CYCLIC GROUP FOR USE IN THE TREATMENT OF CNS DISORDERS | 2019 |
|
RU2796006C2 |
| NEUROACTIVE STEROIDS, COMPOSITIONS AND USES THEREOF | 2012 |
|
RU2665571C2 |
| ANTIVIRAL COMPOUNDS | 2009 |
|
RU2505540C2 |
